BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh
BBCi CATEGORIES   TV   RADIO   COMMUNICATE   WHERE I LIVE   INDEX    SEARCH 

BBC NEWS
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 


Commonwealth Games 2002

BBC Sport

BBC Weather

SERVICES 
Tuesday, 18 September, 2001, 07:16 GMT 08:16 UK
Winning the superbug war
Scientists are developing effective new antibiotics BBC
Scientists are developing effective new antibiotics
The battle to develop antibiotics to treat "superbugs" is being won, says a leading expert.

There has been a lot of concern over the rise of drug-resistant bacteria.


The really big resistance problem is in hospitals

Professor David Livermore
But Professor David Livermore, director of the Antibiotic Resistance Monitoring and Reference Laboratory, London, UK, says new drugs do offer hope.

Speaking at the Public Health Laboratory Service Annual Scientific Conference in Warwick on Monday, he said it was important to keep ahead of the bacteria - which mutate to take account of new drugs developed to fight them.

It is in hospitals that the key fight to develop new antibiotics is being fought - and to some extent won.

'Fatal infections'

At any one time, 9% of patients in NHS hospitals are suffering from an infection acquired while on wards or in surgery, according to the National Audit Office.

It has estimated around 5,000 patients die every year, because of these infections, costing the NHS 1 billion annually.

Urinary tract infections are particularly common, but surgical wounds, skin and the bloodstream can all be infected with potentially deadly bacteria.

Scientists have to find antibiotics to treat two families of bacteria.

Gram positive bacteria include methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci - two notorious superbugs.

In development

Drugs are available, or in development, which can treat these. At the forefront are antibiotics called Synercid and Linezolid. Two more, Daptomycin and Oritacancin, are in development.

But the other "family" of bacteria - gram negative, particularly a type called Pseudomonas, are proving harder to treat.

Professor Livermore told BBC News Online: "We have got treatment options available for these particular, gram positive, forms of bacteria."

But he said: "Against gram negative, there are very few antibiotics."

There have also been fears that too much of prescribing of antibiotics by GPs has meant the drugs will be less effective for patients.

Professor Livermore said "less and better" prescribing of antibiotics would slow the development of resistance against the drugs.

But he said scientists had to keep "one step ahead" as bacteria became resistant to new antibiotics.

Professor Livermore added: "The really big resistance problem is in hospitals rather than in the community."

See also:

25 May 01 | Health
'Birth of a superbug'
19 Apr 01 | Health
Breakthrough in 'superbug' battle
08 Mar 01 | Sci/Tech
Superbug genetic trigger identified
25 Apr 00 | Health
Gene warfare against superbugs
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories